These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 39217477)

  • 1. Risk prediction of cardiovascular disease in the Asia-Pacific region: the SCORE2 Asia-Pacific model.
    ; ; ; ;
    Eur Heart J; 2024 Sep; ():. PubMed ID: 39217477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.
    SCORE2 working group and ESC Cardiovascular risk collaboration
    Eur Heart J; 2021 Jul; 42(25):2439-2454. PubMed ID: 34120177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.
    SCORE2-OP working group and ESC Cardiovascular risk collaboration
    Eur Heart J; 2021 Jul; 42(25):2455-2467. PubMed ID: 34120185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe.
    SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration
    Eur Heart J; 2023 Jul; 44(28):2544-2556. PubMed ID: 37247330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions.
    Hageman SHJ; Kaptoge S; de Vries TI; Lu W; Kist JM; van Os HJA; Numans ME; Läll K; Bobak M; Pikhart H; Kubinova R; Malyutina S; Pająk A; Tamosiunas A; Erbel R; Stang A; Schmidt B; Schramm S; Bolton TR; Spackman S; Bakker SJL; Blaha M; Boer JMA; Bonnefond A; Brenner H; Brunner EJ; Cook NR; Davidson K; Dennison E; Donfrancesco C; Dörr M; Floyd JS; Ford I; Fu M; Gansevoort RT; Giampaoli S; Gillum RF; Gómez-de-la-Cámara A; Håheim LL; Hansson PO; Harms P; Humphries SE; Ikram MK; Jukema JW; Kavousi M; Kiechl S; Kucharska-Newton A; Pablos DL; Matsushita K; Meyer HE; Moons KGM; Mortensen MB; Muilwijk M; Nordestgaard BG; Packard C; Pamieri L; Panagiotakos D; Peters A; Potier L; Providencia R; Psaty BM; Ridker PM; Rodriguez B; Rosengren A; Sattar N; Schöttker B; Schwartz JE; Shea S; Shipley MJ; Sofat R; Thorand B; Verschuren WMM; Völzke H; Wareham NJ; Westbury L; Willeit P; Zhou B; Danesh J; Visseren FLJ; Di Angelantonio E; Pennells L; Dorresteijn JAN
    Eur J Prev Cardiol; 2024 Oct; 31(14):1690-1699. PubMed ID: 38752762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2.
    Hageman SHJ; Petitjaen C; Pennells L; Kaptoge S; Pajouheshnia R; Tillmann T; Blaha MJ; McClelland RL; Matsushita K; Nambi V; Klungel OH; Souverein PC; van der Schouw YT; Verschuren WMM; Lehmann N; Erbel R; Jöckel KH; Di Angelantonio E; Visseren FLJ; Dorresteijn JAN
    Eur J Prev Cardiol; 2023 Oct; 30(15):1705-1714. PubMed ID: 37264679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCORE2 cardiovascular risk prediction models in an ethnic and socioeconomic diverse population in the Netherlands: an external validation study.
    Kist JM; Vos RC; Mairuhu ATA; Struijs JN; van Peet PG; Vos HMM; van Os HJA; Beishuizen ED; Sijpkens YWJ; Faiq MA; Numans ME; Groenwold RHH
    EClinicalMedicine; 2023 Mar; 57():101862. PubMed ID: 36864978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC-Norfolk prospective population cohort.
    van Trier TJ; Snaterse M; Boekholdt SM; Scholte Op Reimer WJM; Hageman SHJ; Visseren FLJ; Dorresteijn JAN; Peters RJG; Jørstad HT
    Eur J Prev Cardiol; 2024 Jan; 31(2):182-189. PubMed ID: 37793098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the SCORE2 risk prediction algorithm in a Portuguese population: A new model to estimate 10-year cardiovascular disease incidence in Europe.
    Temtem M; Mendonça MI; Santos M; Sá D; Sousa F; Freitas S; Borges S; Henriques E; Rodrigues M; Soares C; Rodrigues R; Serrão M; Drumond A; Sousa AC; Palma Reis R
    Rev Port Cardiol; 2024 Aug; 43(8):437-444. PubMed ID: 38395299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of SCORE2 on a sample from the Russian population and adaptation for the very high cardiovascular disease risk region.
    Svinin GE; Kutsenko VA; Shalnova SA; Yarovaya EB; Imaeva AE; Balanova YA; Kapustina AV; Muromtseva GA; Drapkina OM
    PLoS One; 2024; 19(4):e0300974. PubMed ID: 38630773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions.
    WHO CVD Risk Chart Working Group
    Lancet Glob Health; 2019 Oct; 7(10):e1332-e1345. PubMed ID: 31488387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individuals.
    Yari A; Ueda P; Lundman P; Alfredsson J; Ravn-Fischer A; Söderberg S; Yndigegn T; Hagström E; Jernberg T
    Eur J Prev Cardiol; 2024 Nov; 31(15):1890-1897. PubMed ID: 38842486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of Five Different Risk Models In Primary Prevention Guidelines.
    Sud M; Sivaswamy A; Austin PC; Abdel-Qadir H; Anderson TJ; Naimark DMJ; Lee DS; Roifman I; Thanassoulis G; Tu K; Wijeysundera HC; Ko DT
    Eur Heart J Qual Care Clin Outcomes; 2024 May; ():. PubMed ID: 38734893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys.
    Ueda P; Woodward M; Lu Y; Hajifathalian K; Al-Wotayan R; Aguilar-Salinas CA; Ahmadvand A; Azizi F; Bentham J; Cifkova R; Di Cesare M; Eriksen L; Farzadfar F; Ferguson TS; Ikeda N; Khalili D; Khang YH; Lanska V; León-Muñoz L; Magliano DJ; Margozzini P; Msyamboza KP; Mutungi G; Oh K; Oum S; Rodríguez-Artalejo F; Rojas-Martinez R; Valdivia G; Wilks R; Shaw JE; Stevens GA; Tolstrup JS; Zhou B; Salomon JA; Ezzati M; Danaei G
    Lancet Diabetes Endocrinol; 2017 Mar; 5(3):196-213. PubMed ID: 28126460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the European SCORE2 models in a Canadian primary care cohort.
    Sud M; Sivaswamy A; Austin PC; Abdel-Qadir H; Anderson TJ; Khera R; Naimark DMJ; Lee DS; Roifman I; Thanassoulis G; Tu K; Wijeysundera HC; Ko DT
    Eur J Prev Cardiol; 2024 Apr; 31(6):668-676. PubMed ID: 37946603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the general Framingham Risk Score (FRS), SCORE2, revised PCE and WHO CVD risk scores in an Asian population.
    Kasim SS; Ibrahim N; Malek S; Ibrahim KS; Aziz MF; Song C; Chia YC; Ramli AS; Negishi K; Mat Nasir N
    Lancet Reg Health West Pac; 2023 Jun; 35():100742. PubMed ID: 37424687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tai chi for primary prevention of cardiovascular disease.
    Hartley L; Flowers N; Lee MS; Ernst E; Rees K
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010366. PubMed ID: 24715694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries.
    Uthman OA; Hartley L; Rees K; Taylor F; Ebrahim S; Clarke A
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011163. PubMed ID: 26272648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCORE2 Assessment in the Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis.
    Ferraz-Amaro I; Corrales A; Atienza-Mateo B; Vegas-Revenga N; Prieto-Peña D; Sánchez-Martín J; Almeida C; Quevedo-Abeledo JC; Blanco R; González-Gay MÁ
    Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.